Combating new bioweapon risks: A Q&A with Dr Miranda Smith on the European Biotech Act

In this Q&A, Smith talks about why the European Biotech Act is significant, the new biosecurity risks emerging in the era of rapidly developing artificial intelligence (AI), and what the Act can and cannot do.

Source: SIPRI